“…Whereas a radical or modified radical mastectomy used to be the standard treatment, it is now clear that in appropriate cases breast-conserving treatment achieves equivalent long-term survival rates (Veronesi et al, 1981;Sarrazin et al, 1983;Fisher et al, 1985;Van Dongen et al, 1991;Lichter et al, 1992). Furthermore, in the past 10 years it has become increasingly apparent that systemic adjuvant therapy following surgery leads to a reduction in recurrence rates and mortality (Early Breast Cancer Trialists' Collaborative Group, 1992).…”